Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 887 of 1,261
  1. US 8366662

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  2. US 8367052

    Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies

    GENERAL REGENERATIVES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  3. US 8367106

    Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  4. US 8367690

    Aminopyridine derivatives having aurora a selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  5. US 8367841

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  6. WO 2013014107

    SÉMULOPARINE POUR L'AMÉLIORATION DE LA SURVIE DE PATIENTS ATTEINTS D'UN CANCER

    AVENTIS PHARMA SA [FR] · Granted Jan 31, 2013 · Expires Jan 26, 2033

    granted
  7. WO 2013015774

    DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE

    BIOLITEC PHARMA MARKETING LTD [MY] · Granted Jan 31, 2013 · Expires Jan 26, 2033

    granted
  8. US 8361743

    Biological production of zeaxanthin and carotenoid biosynthesis control

    Aquapharm Bio-Discovery Ltd. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  9. US 8361459

    Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  10. US 8362253

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  11. US 8361982

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  12. US 8362235

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  13. US 8362277

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  14. US 8361958

    Oximyl HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  15. US 8362044

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  16. US 8362060

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  17. US 8361772

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  18. US 8360765

    Systems and method for forming a coaxial implant

    Covidien LP · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  19. US 8362211

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  20. US 8361756

    Bifidobacterial gene sequences and their use

    The Regents of the University of California · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  21. US 8361968

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  22. US 8362043

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  23. US 8361508

    Endocytotic particles

    The Board of Regents of the University of Texas System · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  24. US 8361707

    Methods for detecting a Mycobacterium tuberculosis infection

    The United States of America—Department of Veterans Affairs · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.